Affimed Announces Dosing of First Patient in Phase 1 Clinical Trial of Cord Blood-derived Natural Killer Cells in Combination with the Innate Cell Engager AFM13
October 6, 2020
October 6, 2020
September 29, 2020
September 2, 2020
August 11, 2020
August 5, 2020
August 4, 2020
July 10, 2020
June 23, 2020
June 22, 2020
June 17, 2020